|Articles|July 1, 2018
- BioPharm International-07-01-2018
- Volume 31
- Issue 7
BioPharm International, July 2018 Issue (PDF)
Click the title above to open the BioPharm International July 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 7 years ago
Seeking Regulatory Adviceover 7 years ago
Be Quick, But Don’t Hurryover 7 years ago
Biopharma Seeks Balanceover 7 years ago
Industry 4.0 in Biopharmaceutical Manufacturingover 7 years ago
Biosimilars Raise Manufacturing and Regulatory Challengesover 7 years ago
Advances in Analytics for Bioprocessingover 7 years ago
A Look into the Future of Biopharmaceutical Qualityover 7 years ago
Regulating Biologicsover 7 years ago
The Challenge of Disruptive Technologies in BioprocessingNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report
2
Everything to Know About Cell and Gene Therapy in 2025
3
Overcoming Funding Challenges and Maintaining Optimism in CGTs (Part 1)
4
CGT Innovations: The Three-Pronged Strategy for Industry Growth (Part 2)
5
